1. The Committee of the
Americas for the Harmonization of Registration and Control
of Veterinary Medicines is created in the frame of the OIE
Commission for the Americas. This Committee shall be constituted
by the Representatives of the Official Services of the OIE
Member countries and/or responsible for registration and control
of Veterinary Medicines that show interest in participating
in this Committee. The country member representative will
have voice and vote. Any other specialist from the countries
may participate in the meetings, too, but will have only voice.
There is only one vote per country.
2. The objectives of CAMEVET are:
(a) Coordinate the technical information
for the Registration and Control of Veterinary Medicines with
the intention of harmonizing the technical procedures to improve
the quality of the veterinary medicines and the trade of the
products among the countries.
(b) Change of information about Norms and Rules for Registration
and Control, manufacturing, distribution and trade of Veterinary
Medicines. Also change of information about the operation
of factories, warehouses and distribution, attesting the quality,
efficiency and innocuity of the product, with the intention
of harmonizing and homologating the countries Norms on Registration
and Control of veterinary medicines.
(c) Promote compilation, systematization and release of information
as to facilitate change of information among the members of
CAMEVET, by means of the information on technology systems
in coordination with OIE/OPS, and the operation of IMPPAZ
(d) Facilitate the entering of information for the members
of CAMEVET to know techniques and scientific advances dealing
with quality and control of veterinary medicines.
(e) Organize periodically meetings and Seminars in order to
change information among the countries and to take measures
for the implementation of harmonization of registration and
control of veterinary medicines.
3. The President of the CAMEVET will be
the Representative of the country organizing the next Seminar
and the Vice-president will be the Representative of the country
organizing the precedent meeting.
4. The Regional Representation of OIE will work as Secretary
“ex – officio” and will have the following
(a) Inform the CB of OIE and the members of the CAMEVET on
the facts and actions taken on the matter e.g. technical meetings,
Seminars, electronic conferences or any other means of communication
to inform the countries on relevant aspects about Registration
and Control of Veterinary Medicines.
(b) Support meetings and seminars and make the secretariat
work as setting up the logistic and the methodology for organization
of the meetings, distributing the information and documents
on the conclusions of the meetings and providing the CAMEVET
members information on any aspect related to such meetings
5. CAMEVET will be constituted by the official
members representing the countries of the Region, as well
as by collaborators and the adherent members.
The COLLABORATOR MEMBERS can be the
Officially Regulatory Entities of the country members of OIE
-whether they belong the Americas or not-, the OIE Collaborating
Centers, OIE Reference Laboratories and the Universities and
Scientific Institutions recognized by OIE.
The ADHERENT MEMBERS can be the Chambers of the Veterinary
Industry from the OIE country members that may collaborate
providing technical and commercial information regarding Registration
and Control of Veterinary Medicines. The adherent members
will pay an annual fee according to the Official Committee
criteria. This fee will be collected by the Secretary “ex
– officio” as to cover the administrative operating
costs of the Committee and the costs of the Seminars and Meetings.
The Secretary “ex – officio” will provide
the CB of OIE and to the CAMEVET an annual account statement.
The Collaborator and the Adherent members as well, may participate
in all the activities of CAMEVET and may participate in the
meetings and Seminars having voice in the matter but not vote.